文献速递中医儿科中药与中成药合理使用

小儿泻泄停颗粒幼年大鼠毒性评估

Assessment of Xiao'er Xiexieting Keli-induced toxicity in juvenile rats.
PubMed 文献 · J Ethnopharmacol · 2026-07-13

该研究评估小儿泻泄停颗粒(XXTK)在幼年大鼠中的毒性:急性毒性试验单次灌胃253.13 g/kg观察14天,亚急性毒性试验每日灌胃1.74、8.71或32.66 g/kg连续六周并恢复四周。急性试验无死亡,最大耐受量为253.13 g/kg;亚急性试验所有变化可逆、轻微且无毒理学意义,未观察到有害作用剂量为32.66 g/kg/天。结论认为XXTK在幼年大鼠中具有良好毒理学安全性,支持其儿童扩展临床使用潜力,建议进一步评估儿童发育相关指标并在儿科临床队列中验证。

要点

  • 急性毒性试验单次灌胃253.13 g/kg,幼年大鼠无死亡,最大耐受量为253.13 g/kg。
  • 亚急性毒性试验未观察到有害作用剂量为32.66 g/kg/天,所有变化可逆且无毒理学意义。
  • 研究提示XXTK在幼年大鼠中安全性良好,但儿童发育指标及临床验证仍需进一步开展。

核心结论

  • 小儿泻泄停颗粒在幼年大鼠中表现出良好的毒理学安全性,支持其儿童扩展临床使用潜力,建议进一步评估儿童发育相关指标并在儿科临床队列中验证。

研究设计与样本

  • 急性毒性试验(研究1):出生后第24天(PND24)大鼠单次口服253.13 g/kg XXTK,观察14天。
  • 亚急性毒性试验(研究2):PND21大鼠每日口服1.74、8.71或32.66 g/kg XXTK,连续六周,恢复四周。

主要发现

  • 研究1中无死亡或显著发现,最大耐受量为253.13 g/kg。
  • 研究2中所有变化可逆、轻微且无毒理学意义,未观察到有害作用剂量为32.66 g/kg/天。

关键数值与推荐

  • 急性毒性试验最大耐受量为253.13 g/kg。
  • 亚急性毒性试验未观察到有害作用剂量为32.66 g/kg/天。

临床怎么用

  • 为儿童用药剂量和安全性的评估提供幼年大鼠毒理学依据,支持扩展临床使用潜力。
  • 临床使用时仍需关注儿童发育相关指标,并建议在儿科临床队列中进一步验证。

局限性

  • 研究仅为幼年大鼠动物实验,缺乏儿童临床数据。
  • 儿童发育相关指标需进一步评估,并需在儿科临床队列中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Sufficient safety data on juvenile development is not available for Xiao'er Xiexieting Keli (XXTK), a Chinese herbal formula for pediatric diarrhea. AIM OF THE STUDY: Considering the challenges associated with clinical trials of XXTK, this study was aimed at evaluating its toxicity in juvenile rats to obtain a basis for assessing its safety and dosage in children. MATERIALS AND METHODS: In acute toxicity study (Study 1), postnatal day (PND) 24 rats were orally administered 253.13 g/kg XXTK and observed over 14 days. In subacute toxicity study (Study 2), PND21 rats were administered 1.74, 8.71, or 32.66 g/kg XXTK daily for six consecutive weeks and allowed to recover for 4 weeks. Clinical signs, body weight, food intake, and timing of vaginal opening and preputial separation were recorded during the dosing period. Hematological, serum biochemical, and histopathological examinations, Irwin's test, and assessment of growth hormone levels, skeletal development, and immune-related indicators were performed mid-administration, and at culmination of dosing and recovery. Urinalysis, ophthalmological assessment, and Morris water maze test were conducted at the end of dosing and recovery periods. RESULTS: No deaths or significant findings occurred in Study 1; maximum tolerated dose was 253.13 g/kg. In Study 2, all changes were reversible, mild, and without toxicological significance. The no-observed-adverse-effect level was 32.66 g/kg/day. CONCLUSION: XXTK demonstrated a favorable toxicological safety profile in juvenile rats, supporting its potential for extended clinical use in children. Further evaluation of child development-related indicators and validation in pediatric clinical cohorts are recommended.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Liu J, Zhu L, Lu X, et al. Assessment of Xiao'er Xiexieting Keli-induced toxicity in juvenile rats. J Ethnopharmacol. 2026. PMID: 42442643. doi:10.1016/j.jep.2026.122185

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。